| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2013 | US8426461 Orally dispersible tablet |
| 04/23/2013 | US8426460 Dimeric avermectin and milbemycin derivatives |
| 04/23/2013 | US8426459 Composition of flavanolignan and amino acid with improved water solubility |
| 04/23/2013 | US8426458 Hepatitis C Virus inhibitors |
| 04/23/2013 | US8426457 immune response modifier imiquimod; certain immune response modifier (IRM) compounds can be used to improve skin quality |
| 04/23/2013 | US8426455 Prophylactic and/or therapeutic agent for hyperlipidemia |
| 04/23/2013 | US8426454 Therapeutic compounds |
| 04/23/2013 | US8426453 Treatment of a stomach or small intestine ulcer with 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid |
| 04/23/2013 | US8426452 Process for the treatment and prevention of diseases caused by fungi |
| 04/23/2013 | US8426451 Coloring an additive with a colorant such as food yellow No. 5, mixing the resultant additive with a base compound such as amlodipine or a pharmaceutically acceptable salt thereof, and tableting the mixture; improved in light stability |
| 04/23/2013 | US8426450 Substituted 4-phenyl pyridines having anti-emetic effect |
| 04/23/2013 | US8426448 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands |
| 04/23/2013 | US8426447 Spiro-tricyclic ring compounds as beta-secretase modulators and methods of use |
| 04/23/2013 | US8426446 Acrylamide derivative and use thereof in manufacture of medicament |
| 04/23/2013 | US8426445 Iminosugars and methods of treating bunyaviral and togaviral diseases |
| 04/23/2013 | US8426444 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 04/23/2013 | US8426443 Compounds which have activity at M1 receptor and their uses in medicine |
| 04/23/2013 | US8426442 Compounds |
| 04/23/2013 | US8426441 Inhibitors of bruton's tyrosine kinase |
| 04/23/2013 | US8426440 Indolymaleimide derivatives |
| 04/23/2013 | US8426439 Compositions and methods for prophylaxis and treatment of addictions |
| 04/23/2013 | US8426438 Heterocyclic-fused pyrazolo[4,3-c]pyridin-3-one M1 receptor positive allosteric modulators |
| 04/23/2013 | US8426437 Pyrroloquinoline derivatives and their use as protein kinases inhibitors |
| 04/23/2013 | US8426436 Heterocyclic cyclopamine analogs and methods of use thereof |
| 04/23/2013 | US8426434 Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile |
| 04/23/2013 | US8426433 Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution |
| 04/23/2013 | US8426432 Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties |
| 04/23/2013 | US8426431 Substituted 2-aminoacetamides and the use thereof |
| 04/23/2013 | US8426430 Quinazoline derivatives |
| 04/23/2013 | US8426429 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) |
| 04/23/2013 | US8426428 EGFR kinase knockdown via electrophilically enhanced inhibitors |
| 04/23/2013 | US8426427 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes |
| 04/23/2013 | US8426426 Gyrase inhibitors and uses thereof |
| 04/23/2013 | US8426425 Aminopyrimidines useful as inhibitors of protein kinases |
| 04/23/2013 | US8426424 Certain substituted amides, method of making, and method of use thereof |
| 04/23/2013 | US8426423 e.g. 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxyl}-3,4-dihydrocarbostyril; serotonin receptor agonist; antidepressant, anxilytic agent; psychological disorders; autism, Down's syndrome, attention deficit hyper-activity disorder (ADHD), Alzheimer's disease, Parkinson's disease , |
| 04/23/2013 | US8426422 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/23/2013 | US8426421 Protease inhibitors |
| 04/23/2013 | US8426420 Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists |
| 04/23/2013 | US8426419 Tyrosine kinase inhibitors containing a zinc binding moiety |
| 04/23/2013 | US8426418 Method to treat melanoma in BRAF inhibitor-resistant subjects |
| 04/23/2013 | US8426417 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 04/23/2013 | US8426416 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 04/23/2013 | US8426415 Human ADAM-10 inhibitors |
| 04/23/2013 | US8426414 Modulators of G protein-coupled receptor 88 |
| 04/23/2013 | US8426413 Diaryl substituted alkanes |
| 04/23/2013 | US8426412 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides |
| 04/23/2013 | US8426411 Tricyclic compounds |
| 04/23/2013 | US8426410 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders |
| 04/23/2013 | US8426409 7-tert-Butyl-3-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-3H-quinazolin-4-one; arthritis; inhibit Btk |
| 04/23/2013 | US8426408 Pyrimidine inhibitors of kinases |
| 04/23/2013 | US8426407 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1H)pyridone compounds and salts thereof and their applications |
| 04/23/2013 | US8426406 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivatives having substituted oxy group |
| 04/23/2013 | US8426405 Thiazopyrimidinones and uses thereof |
| 04/23/2013 | US8426404 e.g. 3-[1-(6-Amino-pyrimidin-4-yl)-1H-benzoimidazol-2-ylamino]-4-methyl-N-[4-(2-methyl-imidazol-1-yl)-3-trifluoromethyl-phenyl]-benzamide; receptor and non-receptor tyrosine kinases and serine/threonine kinases inhibitor; antiproliferative agent; immune and nervous system disorders |
| 04/23/2013 | US8426403 Gamma secretase modulators |
| 04/23/2013 | US8426402 Benzodiazepine derivatives |
| 04/23/2013 | US8426401 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 04/23/2013 | US8426400 β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 04/23/2013 | US8426399 Methods of treating hypertriglyceridemia |
| 04/23/2013 | US8426398 Conjugates of noscapine and folic acid and their use in treating cancer |
| 04/23/2013 | US8426397 3 (3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives |
| 04/23/2013 | US8426396 Treatment for achondroplasia |
| 04/23/2013 | US8426395 Preparations containing creatine and imino sugars |
| 04/23/2013 | US8426394 Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc |
| 04/23/2013 | US8426393 Inhaled combination therapy |
| 04/23/2013 | US8426392 Method for providing emergency contraception |
| 04/23/2013 | US8426391 Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 |
| 04/23/2013 | US8426390 Triazene compounds for the treatment of cancer |
| 04/23/2013 | US8426389 Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
| 04/23/2013 | US8426388 Prodrugs of HIV protease inhibitors |
| 04/23/2013 | US8426387 Treatments for cancer |
| 04/23/2013 | US8426386 NK1 receptor antagonist composition |
| 04/23/2013 | US8426385 Pharmaceutical composition comprising cyclodextrin paclitaxel inclusion and preparation method thereof |
| 04/23/2013 | US8426384 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 04/23/2013 | US8426383 Anti-aging composition for external use comprising low and high molecular weight hyaluronic acids and the polysaccharides extracted from root bark of Ulmus davidiana |
| 04/23/2013 | US8426382 Polysaccharides comprising carboxyl functional groups substituted by a hydrophobic alcohol derivative |
| 04/23/2013 | US8426381 Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
| 04/23/2013 | US8426377 iRNA agents with biocleavable tethers |
| 04/23/2013 | US8426376 Angiogenesis inhibitor |
| 04/23/2013 | US8426373 Stable pharmaceutical composition comprising beta-lactam antibiotic and ion-chelating agent |
| 04/23/2013 | US8426372 Fungicidally active compound combinations |
| 04/23/2013 | US8426371 Biologically active extract from Dendrobium plant, use thereof and process for preparing the same |
| 04/23/2013 | US8426370 Diaryl hepatonoid-based compounds and use thereof |
| 04/23/2013 | US8426369 Prevention and treatment of colon cancer |
| 04/23/2013 | US8426356 Aminothiazoles and their uses |
| 04/23/2013 | US8426198 In vitro differentiated cell and human embryonic stem cell population |
| 04/23/2013 | US8426169 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |
| 04/23/2013 | US8426145 Diagnostic method for celiac sprue |
| 04/23/2013 | US8425955 Nutritional composition with prebiotic component |
| 04/23/2013 | US8425944 Flavored colonic cleansing system |
| 04/23/2013 | US8425939 Remedy |
| 04/23/2013 | US8425938 Pharmaceutical composition |
| 04/23/2013 | US8425937 Pharmaceutical compositions for glucocorticoid replacement therapy |
| 04/23/2013 | US8425933 Abuse-resistant oral dosage forms and method of use thereof |
| 04/23/2013 | US8425929 Sustained release intraocular implants and methods for preventing retinal dysfunction |
| 04/23/2013 | US8425923 water in oil emulsions comprising polyethersiloxane graft polymers, combination with silicone fluids, gums or elastomers and anhydrous polyethers, used as lubricants on the skin |
| 04/23/2013 | US8425922 Adjuvant compositions and methods of use |
| 04/23/2013 | US8425921 Lipid raft, caveolin protein, and caveolar function modulation compounds and associated synthetic and therapeutic methods |
| 04/23/2013 | US8425908 Treatment with anti-ErbB2 antibodies |